Literature DB >> 15685542

Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis.

Kentaro Kikuchi1, Zhe-Xiong Lian, Guo-Xiang Yang, Aftab A Ansari, Susumu Ikehara, Marshall Kaplan, Hiroshi Miyakawa, Ross L Coppel, M Eric Gershwin.   

Abstract

BACKGROUND AND AIMS: Sera from patients with primary biliary cirrhosis (PBC) are characterized by the presence of antimitochondrial antibodies and elevated levels of immunoglobulin (Ig) M. We hypothesized that the increase in serum IgM is the result of chronic B-cell activation induced via the Toll-like receptor (TLR) signaling pathway.
METHODS: We analyzed peripheral blood mononuclear cells (PBMCs) from patients with PBC and controls following incubation with CpG, a natural ligand for TLR9, and determined the basal and stimulated levels of intracellular IgM, the density of TLR9, and the contribution of specific B-cell subpopulations.
RESULTS: Our data demonstrate uniquely that in vitro incubation of PBMCs from PBC with CpG-B, but not CpG-A, led to a markedly high frequency of intracellular IgM-positive B cells, associated with high levels of synthesized IgM and identified to be a function of CD27(+) memory B cells. This memory B-cell subset also expressed higher densities of TLR9 as compared with naive B cells. These results were not due to increased proliferation, as defined by 5-carboxyfluoresein diacetate succinimidyl ester labeling, or an increase in the life span of B cells, as defined by Bcl-2 expression.
CONCLUSIONS: These findings for the first time identify a major role for innate immune mechanisms in the induction and persistence of abnormal humoral immune responses in PBC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685542     DOI: 10.1053/j.gastro.2004.11.005

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  44 in total

1.  The immunopathology of liver granulomas in primary biliary cirrhosis.

Authors:  Zhengrui You; Qixia Wang; Zhaolian Bian; Yuan Liu; Xiaofeng Han; Yanshen Peng; Lei Shen; Xiaoyu Chen; Dekai Qiu; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  J Autoimmun       Date:  2012-06-23       Impact factor: 7.094

Review 2.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 3.  Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

Authors:  E Cario
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

Review 4.  Pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

5.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

Review 6.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 7.  Animal models of primary biliary cirrhosis.

Authors:  Ya-Hui Chuang; William M Ridgway; Yoshiyuki Ueno; M Eric Gershwin
Journal:  Clin Liver Dis       Date:  2008-05       Impact factor: 6.126

8.  Apotopes and the biliary specificity of primary biliary cirrhosis.

Authors:  Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; Ross L Coppel; Ian R Mackay; Gregory J Gores; Aftab A Ansari; Judy Van de Water; M Eric Gershwin
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

9.  Genomic variants associated with primary biliary cirrhosis.

Authors:  Carlo Selmi; Natalie J Torok; Andrea Affronti; M Eric Gershwin
Journal:  Genome Med       Date:  2010-01-26       Impact factor: 11.117

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.